Board Member
Alto Neuroscience, Inc. (ANRO)Equibles does not estimate personal net worth.
Get an email with a short summary when Alto Neuroscience, Inc. publishes a filing, an earnings call transcript or a press release.
Get ANRO alertsAmit Etkin is recorded as Board Member and CEO at Alto Neuroscience, Inc. (ANRO). The newest filing on record that lists Amit Etkin as Board Member and CEO at Alto Neuroscience, Inc. (ANRO) is dated March 26, 2026. The proxy statement of Alto Neuroscience, Inc. reports total compensation of $2,188,487 for Amit Etkin in fiscal 2025, including a base salary of $650,671. Disclosed compensation is on record for 2 fiscal years. Amit Etkin has spoken on 3 investor events across 1 company, most recently for Alto Neuroscience, Inc. on September 14, 2026. Alto Neuroscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alto Neuroscience, Inc. includes Nicholas Smith (CFO), Michael Hanley (COO), Andrew Dreyfus (Board Member) and 7 others.
“So Alto Neuroscience is a late-stage psychiatric drug developer. We focus on areas like treatment-resistant depression, bipolar depression, and a range of related conditions.”
“So I think actually it's important to start by even understanding what TRD really means, because I actually think that the TRD definition that people have sort of moved to in their minds is actually perhaps more narrow than the real opportunity out there.”
“I'm the founder and CEO of Alto Neuroscience. Thank you for having us at the B of A conference. I want to take you through the story, focusing really on Alto 207, one of the most important programs in our pipeline.”
Start not stated–present
Last confirmed March 26, 2026
Start not stated–present
Last confirmed March 26, 2026
Biotechnology · Healthcare
Board Member, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alto Neuroscience, Inc. (ANRO) | M.D., Ph.D. President, Chief Executive Officer, and Chair of the Board | $650,671 | $2,188,487 |
| 2024 | Alto Neuroscience, Inc. (ANRO) | M.D., Ph.D. President, Chief Executive Officer, and Chair of the Board | $603,050 | $4,065,848 |
